SubjectWell, the patient recruitment vendor, announced it has expanded its patient recruitment services into the United Kingdom, Ireland and South Africa. Supplementing its current footprint in the U.S. and Canada, the expansion is part of SubjectWell’s efforts to meet the needs of its pharmaceutical and clinical trial sponsors running global clinical trials, all while continuing to accelerate last patient in (LPI) by increasing awareness of clinical research in the general population and only charging for those patients who randomize.
“With 86 percent of clinical trials operating sites outside of the U.S., a more streamlined and complete risk-free patient recruitment offering with global reach was something our partners consistently requested,” said Ivor Clarke, CEO, SubjectWell. “We look forward to the continued growth of our business in 2020 and beyond, which will introduce millions of people to potentially life-changing clinical trial opportunities.
To further ease the recruitment process and to accommodate sites and sponsors worldwide, SubjectWell has met regulatory framework by complying with the specific requirements for any information collected, such as the requirements of the EU General Data Protection Regulation (GDPR). Under the terms of GDPR, organizations ensure that personal data is gathered with clear disclosures and under strict conditions, protecting businesses and patients alike.
SubjectWell will continue to expand into additional international markets in 2020, strengthening its commitment to serving as a single partner and offering global services to its contract research organizations and sponsors.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.